Главная › Немелкоклеточный рак легкого › Флорида › Miami
Клинические исследования Немелкоклеточный рак легкого в городе Miami, FL
Одно исследование по теме Немелкоклеточный рак легкого ищет участников в центре в городе Miami или поблизости. Откройте его, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Набор участниковФаза 3
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набор участниковФаза 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Набор участниковФаза 1
- Exelixis Clinical Site #47, Miami
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Набор участниковФаза 3
- Miami Cancer Institute, Miami
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Набор участниковФаза 3
- Sylvester Comprehensive Cancer Center Miami, Miami
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Sylvester Comprehensive Cancer Center, Miami
- Baptist Health Miami Cancer Institute, Miami
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- University of Miami, Miami
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Набор участниковФаза 1/2
- Miami Cancer Institute, Miami
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Набор участниковФаза 3
- Local Institution - 0696, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набор участниковФаза 1
- Sylvester Comprehensive Cancer Center, Miami
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Набор участниковФаза 1/2
- Sylvester Comprehensive Cancer Center - Miami, Miami
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Набор участниковФаза 1
- Biogenix Molecular, LLC, Miami
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набор участниковФаза 2/3
- Miami Veterans Affairs Healthcare System, Miami
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набор участниковФаза 1
- University of Miami, Miami
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Sylvester Comprehensive Cancer Center, Miami
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набор участниковФаза 3
- Miami Cancer Institute at Baptist Health, Inc., Miami
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- University of Miami, Miami
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Набор участниковФаза 3
- Miami Cancer Institute at Baptist Health, Miami
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набор участниковФаза 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Miami Cancer Institute, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
ctDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer
Набор участниковФаза 2
- University of Miami, Miami
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Набор участниковФаза 1/2
- Sylvester Comprehensive Cancer Center, Miami
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Набор участниковФаза 2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Bioresearch Partner, Miami
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Набор участниковФаза 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
A Study of VET3-TGI in Patients With Solid Tumors
Набор участниковФаза 1
- University of Miami, Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Набор участниковФаза 2
- Baptist Alliance - McI, Miami
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Набор участников
- Miami VA Healthcare System, Miami, FL, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, Miami
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
Набор участниковНаблюдательное исследование
- Baptist Health South Florida, Miami
Исследования Немелкоклеточный рак легкого в других городах
- Houston, TX145 исследований
- New York City, NY120 исследований
- Arlington, VA104 исследований
- Nashville, TN97 исследований
- Boston, MA90 исследований
- Los Angeles, CA87 исследований
- St. Louis, MO73 исследований
- Chicago, IL61 исследование
- Baltimore, MD60 исследований
- San Antonio, TX59 исследований
- Columbus, OH56 исследований
- Washington, DC55 исследований
Другие исследования в городе Miami
- Рак молочной железы42 исследований
- Рак (все виды)36 исследований
- Рак простаты27 исследований
- Ожирение27 исследований
- Острый миелоидный лейкоз24 исследований
- Метастатический рак24 исследований
- Рак яичников23 исследований
- Избыточный вес23 исследований
- Множественная миелома21 исследование
- Язвенный колит21 исследование
- Болезнь Альцгеймера20 исследований
- Рак легких20 исследований
Источник: ClinicalTrials.gov, данные получены 5 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.